Carcinoembryonic antigen (CEA) in serum and bile of colorectal cancer patients with or without detectable liver metastases - PubMed (original) (raw)
. 1994 May-Jun;14(3B):1409-12.
Affiliations
- PMID: 8067714
Carcinoembryonic antigen (CEA) in serum and bile of colorectal cancer patients with or without detectable liver metastases
M Paganuzzi et al. Anticancer Res. 1994 May-Jun.
Abstract
It has been suggested that bile CEA levels could represent a sensitive index for the detection of occult liver metastases in colorectal cancer (CRC) patients. We measured serum and gallbladder bile CEA concentrations in a control group, in a group of patients with benign disease of the biliary tree, and in patients with CRC at different stages. Neoplastic patients without evidence of liver metastases at the time of laparotomy, but with elevated biliary CEA levels, were selected for a follow-up study. Our results indicate that (a) bile CEA levels are falsely increased in several benign biliary diseases; (b) CRC patients with detectable liver metastases have elevated biliary CEA levels; (c) high biliary CEA levels do not represent a predictive parameter for the presence of occult liver metastases in CRC patients.
Similar articles
- Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen concentration: a prospective study.
Tuech JJ, Pessaux P, Regenet N, Daver A, Lorimier G, Bergamaschi R, Arnaud JP. Tuech JJ, et al. J Surg Oncol. 2004 Oct 1;88(1):27-31. doi: 10.1002/jso.20116. J Surg Oncol. 2004. PMID: 15384059 - Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen.
Novell F, Trias M, Molina R, Filella X. Novell F, et al. Anticancer Res. 1997 Jul-Aug;17(4A):2743-6. Anticancer Res. 1997. PMID: 9252708 - Carcinoembryonic antigen to detect hepatic metastases of colorectal cancers.
Kutun S, Celik A, Hatiboglu C, Ulucanlar H, Cetin A. Kutun S, et al. Surg Today. 2003;33(8):590-4. doi: 10.1007/s00595-003-2546-y. Surg Today. 2003. PMID: 12884096 - Alcohol, carcinoembryonic antigen processing and colorectal liver metastases.
McVicker B, Tuma DJ, Lazure KE, Thomas P, Casey CA. McVicker B, et al. Adv Exp Med Biol. 2015;815:295-311. doi: 10.1007/978-3-319-09614-8_17. Adv Exp Med Biol. 2015. PMID: 25427914 Review. - Carcinoembryonic Antigen (CEA) and Hepatic Metastasis in Colorectal Cancer: Update on Biomarker for Clinical and Biotechnological Approaches.
Campos-da-Paz M, Dórea JG, Galdino AS, Lacava ZGM, de Fatima Menezes Almeida Santos M. Campos-da-Paz M, et al. Recent Pat Biotechnol. 2018;12(4):269-279. doi: 10.2174/1872208312666180731104244. Recent Pat Biotechnol. 2018. PMID: 30062978 Review.
Cited by
- Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence.
Alaiyan B, Ilyayev N, Stojadinovic A, Izadjoo M, Roistacher M, Pavlov V, Tzivin V, Halle D, Pan H, Trink B, Gure AO, Nissan A. Alaiyan B, et al. BMC Cancer. 2013 Apr 17;13:196. doi: 10.1186/1471-2407-13-196. BMC Cancer. 2013. PMID: 23594791 Free PMC article. - Advantages of the AMDL-ELISA DR-70 (FDP) assay over carcinoembryonic antigen (CEA) for monitoring colorectal cancer patients.
Small-Howard AL, Harris H. Small-Howard AL, et al. J Immunoassay Immunochem. 2010;31(2):131-47. doi: 10.1080/15321811003617438. J Immunoassay Immunochem. 2010. PMID: 20391025 Free PMC article. - Natural history of liver metastases from colorectal carcinoma.
Norstein J, Silen W. Norstein J, et al. J Gastrointest Surg. 1997 Sep-Oct;1(5):398-407. doi: 10.1016/s1091-255x(97)80126-6. J Gastrointest Surg. 1997. PMID: 17061331 Review. No abstract available. - Can biliary carcinoembryonic antigen identify colorectal cancer patients with occult hepatic metastases?
Li Destri G, Lanteri R, Santangelo M, Torrisi B, Di Cataldo A, Puleo S. Li Destri G, et al. World J Surg. 2006 Aug;30(8):1494-9. doi: 10.1007/s00268-005-0698-1. World J Surg. 2006. PMID: 16847713
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical